G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Operating Expenses Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Operating Expenses
-kr58.6m
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-17%
AddLife AB
STO:ALIF B
Operating Expenses
-kr2.9B
CAGR 3-Years
-36%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Operating Expenses
-kr1.3B
CAGR 3-Years
-68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Operating Expenses
-kr961m
CAGR 3-Years
-30%
CAGR 5-Years
-18%
CAGR 10-Years
-16%
MedCap AB (publ)
STO:MCAP
Operating Expenses
-kr537.9m
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
M
Magle Chemoswed Holding AB
STO:MAGLE
Operating Expenses
-kr132.3m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Operating Expenses?
Operating Expenses
-58.6m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Operating Expenses amounts to -58.6m SEK.

What is Genovis AB's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-17%

Over the last year, the Operating Expenses growth was -1%. The average annual Operating Expenses growth rates for Genovis AB have been -9% over the past three years , -12% over the past five years , and -17% over the past ten years .

Back to Top